POSTN and cancer: The emergence of ECM signatures to stratify patients with cancer is already providing useful predictors of disease staging130,131, and ECM molecules such as tenascins, periostin, and versicans have been linked to tumour progression and eventually could be used to identify early signs of metastasis133–136.